November 12, 2013
Japan’s National Cancer Center (NCC) and Sanofi K.K. said on November 7 that they have clinched a basic agreement on the clinical development of the pharmaceutical maker’s anticancer drug candidates. Under the accord, the two partners will actively perform domestic...read more